Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Highlight Therapeutics

Clinical trials sponsored by Highlight Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New shot shrinks skin cancer before surgery in early trial Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Completed 1

Experimental combo shows promise for Hard-to-Treat melanoma

Disease control Completed

This phase 2 trial tested a combination of two drugs—BO-112, injected directly into tumors, and pembrolizumab, given through a vein—in 42 adults with advanced melanoma that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors and …

Phase 2 • Sponsor: Highlight Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC